The mTOR pathway is the foremost multifunctional orchestrator of NAFLD/NASH progression and associated HCC development responding to metabolic syndrome, diabetes, hyperinsulinemia, insulin resistance, and dyslipidemia. The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatotic liver disease.